Expression of an oncofetal 65-kDa phosphoprotein in lymphocytic and granulocytic leukemias

International Journal of Hematology

Volumn 63, Issue 3, 1996, Pages 193-203

  Hanausek, Malgorzata ^a   Wang, Saixi C ^a   Blonski, Jerzy Z ^b   Kulesza, Eugenia Polkowska ^b   Walaszek, Zbigniew ^a   Mirowski, Marek ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Acute chronic granulocytic leukemia; Acute chronic lymphocytic leukemia; ELISA; Monoclonal antibodies; p65 Oncofetal protein

Indexed keywords

ONCOFETAL ANTIGEN; PHOSPHOPROTEIN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MYELOID LEUKEMIA; PRIORITY JOURNAL;

EID: 0029967754     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-5710(96)00438-0     Document Type: Article

References (44)

1. Bates SE. Clinical applications of serum tumor markers. Ann Intern Med 1991;115:623-645.
2. Fletcher RH. Carcinoembryonic antigen. Ann Intern Med 1986;104:66-78.
3. Posner MR, Mayer RJ. The use of serologic tumor markers in gastrointestinal malignancies. Hematol Oncol Clin North Am 1994;8:533-553.
4. Urban JL, Schreiber H. Tumor antigens. Ann Rev Immunol 1992;10:617-644.
5. Schreiber H, Ward PL, Rowley DA, Staus HJ. Unique tumor-specific antigens. Ann Rev Immunol 1988;6: 465-483.
6. Boxer GM, Abassis AM, Pedley RB, Begent RHJ. Localization of monoclonal antibodies reacting with epitopes on carcinoembryonic antigen (CEA): implications for target therapy. Br J Cancer 1994;69:307-314.
7. Brissinck J, Demanet C, Moser M, Leo O, Thielemans K. Treatment of mice bearing BCL1 lymphoma with bispecific antibodies. J Immunol 1991;147:4019-4026.
8. Chambost H, Brasseur F, Coulie P, De Plaen E, Stoppa AM, Baume D, Mannoni P, Boon T, Maraninchi D, Olive D. A tumour-associated antigen expression in human haematological malignancies. Br J Haematol 1993;84:524-526.
9. Van Der Bruggen P, Traversari C, Chomez P, Lurquin C, DePlaeu E, Van Den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes of a human melanoma. Science 1991;254: 1643-1647.
10. Lim SH, Marcus RE. Monoclonal antibody (MoAb) therapy in non-Hodgkin's lymphomas. Blood Rev 1992;6:157-162.
11. Scheinberg DA, Lovett D, Divgi CR. A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide. J Clin Oncol 1991;9:478-490.
12. Brown S, Miller RA, Borning SJ. Treatment of B-cell lymphomas with anti-idiotype antibodies and in combination with alpha-interferon. Blood 1989;73:651-661.
13. Chigira M, Arita S, Watanabe H. Myth of tumor immunology (review). Int J Oncol 1993;3:645-654.
14. Waldmann TA. Immune receptors: targets for therapy of leukemia/lymphoma autoimmune diseases and for the prevention of allograft rejection. Annu Rev Immunol 1992;10:675-704.
15. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989;57:327-334.
16. Oikawa S, Inuzuka C, Kuroki M, Matsuoka Y, Kosaki G, Nakazato H. Cell adhesion activity of nonspecific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface. Biochem Biophys Res Commun 1989;164:39-45.
17. Sobol RE, Royston I, LeBien TW, Minowada J, Anderson K, Davey ER, Cuttner J, Schiffer C, Ellison R, Bloomfield CD. Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies. Blood 1985;3:730-735.
18. Pinto A, Gattei V, Soligo D, Parravicini C, Del Vecchio L. New molecules burst at the leukocyte surface: a comprehensive review based on the 5th International Workshop on Leukocyte Differentiation Antigens. Leukemia 1994;8:347-358.
19. Hanausek M, Adams AK, Sherman U. Expression of a 65-kDa tumor-associated protein and persistence of altered hepatic foci. Prog Clin Biol Res 1991; 369:91-103.
20. Mirowski M, Hanausek M, Sherman U, Adams AK, Walaszek Z, Slaga TJ. An enzme-linked immunosorbent assay for p65 oncofetal protein and its potential as a new marker for cancer risk assessment in rodents and human. Prog Clin Biol Res 1991;374:281.
21. Hanausek M, Mirowski M, Sherman U, Tuttle L, Walaszek Z. An oncofetal protein (p65) and its gene expression in hepatocarcinogenesis. Proc Am Assoc Cancer Res 35:153;1994.
22. Hanausek M, Szemraj J, Adams AK, Walaszek Z. The oncofetal protein p65 as a new member of the steroid/thyroid receptor superfamily. Cancer Detect Prev 19:73;1995.
23. Mirowski M, Sherman U, Hanausek M. Purification and characterization of a 65 kDa tumor-associated phosphoprotein from rat transplantable hepatocellular carcinoma 1682 cell line. Protein Exp Purif 1992;3:196-204.
24. Köhler G, Milstein C. Continuous culture of fused cells secreting antibody of predefined specificity. Nature 1975;256:415.
25. Cote GJ, Palmer WN, Leonhart K. The regulation of somatostatin production in human medullary thyroid carcinoma cells by dexamethasone. J Biol Chem 1986;261:12930-12935.
26. Wang S, Mirowski M, Sherman U, Walaszek Z, Hanausek M. Monoclonal antibodies against a novel 65-kDa tumor-associated phosphoprotein: development and use in cancer detection. Hybridoma 1993;12:167-176.
27. Boyum A. Isolation of mononuclear cells and granulo cytes from human blood. Scand J Clin Lab Invest 1968;21:77-89.
28. Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, Masi M, Tabilio A, Papa G. Prognostic values of cell marker analysis in de novo acute myeloid leukemia. Leukemia 1994;8:388-394.
29. De Rossi G, Grossi C, Foa R, Tabilio A, Vegna L, LoCoco F, Annino L, Camera A, Cascavilla N, Ciolli S, Del Poeta G, Liso V, Mandelli F. Immunophenotype of acute lymphoblastic leukemia cells: the experience of the Italian Cooperative Group (Gimema). Leuk Lymphoma 1993;9:221-228.
30. Pins MA, Pezella F, Martinez-Montero JC, Orradre JL, Viluendas R, Sanchez-Beato M, Cuena R, Cruz MA, Martinez B, Garrido MC, Gatter K, Aiello A, Delia D, Giardini R, Rilke F. p53 and bcl-2 expression in high- grade B-cell lymphomas: correlation with survival time. Br J Cancer 1994;69:337-341.
31. Riopel M, Dickman PS, Link MP, Perlman EJ. M1C2 analysis in pediatric lymphomas and leukemias. Hum Pathol 1994;25:396-399.
32. Dixon J, Kaklamanis L, Turley H, Hickson LD, Leek RD, Harris AL, Gatter KC. Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J Clin Pathol 1994;47:43-47.
33. Gazitt Y, Polliack A. Characterzation of GP-70: a novel B-cell leukemia specific antigen and the correlation between GP-70 expression and disease activity. In: Polliack A, Catovsky D (eds). Chronic Lymphocytic Leukemia. London: Harwood Academic 1988;67-84.
34. Faguet GB, Agee JF. Monoclonal antibodies against the chronic lymphocytic antigen, cCLLa: characterization and reactivity. Blood 1987;70:437-443.
35. Van Denderen J, Hacken PT, Berendes P, Van Ewijk W. Detection of tumor specific antigens in Philadelphia chromosome positive leukemias. Leuk Lymphoma 1993;11 (suppl 1):29-32.
36. Gale RP, Caligaris-Capio F, Dighiero G, Keating M, Montserrat E, Rai K. Recent progress in chronic lymphocytic leukemia. Leukemia 1994;8:1610-1614.
37. Kitagawa M, Yoshida S, Kuwata T, Tanizawa T, Kamiyama R. p53 expression in myeloid cells of myelodysplastic syndromes: association with evolution of overt leukemia. Am J Pathol 1994;145:338-344.
38. Korkolopoulou P, Oates J, Kittas C, Crocker J. p53, c-myc, p62, and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas. J Clin Pathol 1994;47:9-14.
39. Kondo E, Yoshino T, Yamadori L, Matsuo Y, Kawasaki N, Mimowada J, Akagi T. Expression of bcl-2 protein and Fas antigen in non-Hodgkin's lymphoma. Am J Pathol 1994;145:330-337.
40. Kanakura Y, Ikeda H, Kitayama H, Suguhara H, Furitsu T. Expression, function and activation of the protooncogene c-kit product in human leukemia cells. Leuk Lymphoma 1993;10:35-41.
41. Lepelley P, Preudhomme C, Vanrumbeke M, Quesnel B, Cosson A, Fenaux P. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis. Leukemia 1994;8:1342-1349.
42. Mirowski M, Klijanienko J, Wang S, Vielh P, Walaszek Z, Hanausek M. Serological and immunohistochemical detection of a 65 kDa protein in breast cancer. Eur J Cancer 1994;30A:1108-1113.
43. O'Malley BW. Did eukaryotic steroid receptors evolve from 'intracrine' gene regulators? Endocrinology 1989;125:1119-1127.
44. Mirowski M, Walaszek Z, Sherman U, Hanausek M. Comparative structural analysis of human and rat 65 kDa tumor associated protein. Int J Biochem 1993;25:1865-1871.